Revolutionizing the Way CRISPR is Used in Plants
Next-generation genomics achieves morphine pathway removal for poppy cultivation and drug development.
Our Science
Employing our patented gene editing processes together with CRISPR technology and cutting-edge farming practices, Emerzene has developed a non-addictive strain of poppy.
We are now able to produce a line of plant-based, morphine-free pain medications to be part of the solution to drug abuse and dependence.
What is CRISPR?
Born to solve global food crisis’, plant disease problems, and world-wide agricultural challenges, Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR) genome-editing technology opens new opportunities to engineer disease resistant cultivation and solve major challenges in crop improvement.
CRISPR technology has been successfully used to engineer plants and crops resistant to bacteria, viruses, fungi, and pests. Through disrupting, deleting, correcting, and inserting genomes with desired traits, CRISPR technology enables development and improvement of critical crops characteristics.
PARTNER WITH US
A Specific, Efficient and Versatile Tool for Editing Genes
Through disrupting, deleting, correcting, and inserting genomes with desired traits, CRISPR technology is able to develop crops that contain all critical characteristics.
CRISPR Applied to Plant-Based Medicine
Searching for a breakthrough in pain relief, Emerzene experts utilized CRISPR mediated genome editing to engineer a unique strain of poppy (P. Bracteatum). Our proprietary poppy strain contains elements needed to product the first ever all-natural, non-addictive pain relief medication.
Our solvent-free extraction
and API manufacturing is being contracted to an established GMP certified facility in Liechtenstein, Europe.
We are actively looking to partner with pharmaceutical companies for our R&D trials to propel the next generation of medicinal advances.
PARTNER WITH US